Corbus Pharmaceuticals Holdings, Inc. (CRBP)
11.21
-0.25
(-2.18%)
USD |
NASDAQ |
Sep 04, 14:21
Corbus Pharmaceuticals Holdings 1 Year Total Returns (Daily) : 16.35% for Sept. 3, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 03, 2026 | 16.35% |
| September 02, 2026 | 17.86% |
| September 01, 2026 | 20.38% |
| August 31, 2026 | 16.44% |
| August 28, 2026 | 10.20% |
| August 27, 2026 | 6.30% |
| August 26, 2026 | 12.66% |
| August 25, 2026 | 14.36% |
| August 24, 2026 | 9.19% |
| August 21, 2026 | 7.01% |
| August 20, 2026 | 6.72% |
| August 19, 2026 | 9.42% |
| August 18, 2026 | 8.97% |
| August 17, 2026 | 13.41% |
| August 14, 2026 | 4.78% |
| August 13, 2026 | 5.11% |
| August 12, 2026 | 8.93% |
| August 11, 2026 | 9.69% |
| August 10, 2026 | 12.22% |
| August 07, 2026 | 13.00% |
| August 06, 2026 | 6.92% |
| August 05, 2026 | 7.53% |
| August 04, 2026 | 0.64% |
| August 03, 2026 | -4.19% |
| July 31, 2026 | -3.24% |
| Date | Value |
|---|---|
| July 30, 2026 | -2.27% |
| July 29, 2026 | -3.78% |
| July 28, 2026 | -5.27% |
| July 27, 2026 | -1.94% |
| July 24, 2026 | 1.78% |
| July 23, 2026 | 6.03% |
| July 22, 2026 | 1.61% |
| July 21, 2026 | 4.91% |
| July 20, 2026 | 4.59% |
| July 17, 2026 | 6.50% |
| July 16, 2026 | 3.29% |
| July 15, 2026 | 11.79% |
| July 14, 2026 | 8.01% |
| July 13, 2026 | 9.31% |
| July 10, 2026 | 15.79% |
| July 09, 2026 | 15.41% |
| July 08, 2026 | 26.66% |
| July 07, 2026 | 28.49% |
| July 06, 2026 | 16.73% |
| July 02, 2026 | 19.35% |
| July 01, 2026 | 26.68% |
| June 30, 2026 | 35.94% |
| June 29, 2026 | 21.35% |
| June 26, 2026 | 8.98% |
| June 25, 2026 | -4.84% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 8.32% |
| Alnylam Pharmaceuticals, Inc. | -40.88% |
| Anika Therapeutics, Inc. | 133.1% |
| Savara, Inc. | 57.02% |
| Vericel Corp. | 20.63% |